Department of Plant Biology and Ecology, University of Sevilla, Sevilla, Spain
Mini Review
Natural PPAR Agonist that Doesn't Cause Corpulence
Author(s): Javier Galán*
In clinical settings, PPAR (peroxisome proliferator-activated receptor gamma) agonists are utilized to combat hyperglycemia. The search for new
PPAR activators, on the other hand, is fueled by the experience of undesirable side effects like weight gain. We utilized a mix of in silico, in vitro,
cell-based and in vivo models to distinguish and approve regular items as promising leads for halfway original PPARγ agonists. It was predicted
in silico that the natural product honokiol from the traditional Chinese medicine Magnolia bark would bind as a dimer into the PPAR ligand binding
pocket. In fact, in a PPAR-mediated luciferase reporter assay, Honokiol acted as a partial agonist by binding directly to the purified LBD of PPAR.
After that, the effects of Honokiol on adipogenic differentiation in 3T3-L1 pre-adipocytes and mouse embryonic fibroblasts and the stimu.. Read More»
DOI:
10.37421/2472-0992.2022.8.196
Journal of Pharmacognosy & Natural Products received 606 citations as per Google Scholar report